Universe · entity
BVF INC/IL
Institutional manager (13F) · CIK 1056807
13F holdings · as of 2026-03-31 · top 41 · reported portfolio $3.1B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | KYMERA THERAPEUTICS INC | $458M | 5,502,710 |
| 2 | MOONLAKE IMMUNOTHERAPEUTICS | $298M | 16,001,284 |
| 3 | REVOLUTION MEDICINES INC | $278M | 2,856,782 |
| 4 | NEKTAR THERAPEUTICS | $184M | 2,559,595 |
| 5 | STRUCTURE THERAPEUTICS INC | $167M | 3,459,358 |
| 6 | MIRUM PHARMACEUTICALS INC | $146M | 1,584,727 |
| 7 | GH RESEARCH PLC | $122M | 8,650,158 |
| 8 | PALVELLA THERAPEUTICS INC NE | $120M | 960,989 |
| 9 | ZYMEWORKS INC | $94M | 3,734,142 |
| 10 | XENCOR INC | $86M | 7,133,720 |
| 11 | STOKE THERAPEUTICS INC | $83M | 2,547,557 |
| 12 | CULLINAN THERAPEUTICS INC | $82M | 5,750,683 |
| 13 | DISC MEDICINE INC | $81M | 1,272,312 |
| 14 | XOMA ROYALTY CORPORATION | $81M | 2,590,303 |
| 15 | OLEMA PHARMACEUTICALS INC | $79M | 5,295,893 |
| 16 | TYRA BIOSCIENCES INC | $76M | 1,976,196 |
| 17 | MONTE ROSA THERAPEUTICS INC | $73M | 4,460,886 |
| 18 | ALKERMES PLC | $71M | 2,000,000 |
| 19 | KURA ONCOLOGY INC | $69M | 8,445,769 |
| 20 | AC IMMUNE SA | $55M | 19,822,436 |
| 21 | CRESCENT BIOPHARMA INC. | $50M | 2,748,763 |
| 22 | ANNEXON INC | $48M | 8,698,173 |
| 23 | COMPASS THERAPEUTICS INC | $41M | 7,764,842 |
| 24 | IMMUNOCORE HLDGS PLC | $39M | 1,294,463 |
| 25 | SEPTERNA INC | $33M | 1,353,249 |
| 26 | SUTRO BIOPHARMA INC | $31M | 1,251,788 |
| 27 | FOGHORN THERAPEUTICS INC | $28M | 5,842,000 |
| 28 | 4D MOLECULAR THERAPEUTICS IN | $27M | 2,879,289 |
| 29 | INVIVYD INC | $25M | 19,525,000 |
| 30 | AVALO THERAPEUTICS INC | $24M | 1,632,845 |
| 31 | ELEDON PHARMACEUTICALS INC | $19M | 6,293,282 |
| 32 | ANTERIS TECHNOLOGIES GLOBAL | $17M | 3,000,000 |
| 33 | X4 PHARMACEUTICALS INC | $9M | 2,233,742 |
| 34 | IMMUNIC INC | $8M | 7,652,972 |
| 35 | ONKURE THERAPEUTICS INC | $8M | 1,978,972 |
| 36 | TSCAN THERAPEUTICS INC | $6M | 5,564,290 |
| 37 | IMAGENEBIO INC | $6M | 1,110,002 |
| 38 | TENAX THERAPEUTICS INC | $5M | 339,549 |
| 39 | MOLECULAR PARTNERS AG | $5M | 1,353,968 |
| 40 | INVENTIVA SA | $4M | 686,040 |
| 41 | ENGENE HOLDINGS INC | $2M | 945,402 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.